Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia
Alexander T. Hardy(University of Birmingham), Francisca Ferrer‐Marín(Centre for Biomedical Network Research on Rare Diseases)
Cited by 41
Related Papers
<i>miR‐146a<sup>−/−</sup></i> mice model reveals that <scp>NF‐κB</scp> inhibition reverts <scp>inflammation‐driven</scp> myelofibrosis‐like phenotype
|American Journal of Hematology|2024|8